Comparison of the cytostatic and cytolytic activity of tumor necrosis factor-α and interleukin 1α in human malignant cell lines

This publication has 13 references indexed in Scilit:

• Common expression of a tumor necrosis factor resistance mechanism among gynecological malignancies
  Cancer Immunology, Immunotherapy, 1990
• Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor
  Cell, 1989
• Potent Inhibition of Interleukin 1β-Mediated Human Melanoma (A375.6) Lysis by Corticosteroids, Staurosporine, and Tilorone
  Immunopharmacology and Immunotoxicology, 1989
• A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients.
  Journal of Clinical Oncology, 1988
• Interleukin-1 Directly Regulates Hormone-Dependent Human Breast Cancer Cell Proliferationin Vitro
  Molecular Endocrinology, 1988
• Interrelated Effects of Tumor Necrosis Factor and Interleukin 1 on Cell Viability
  Immunobiology, 1988
• Mechanism of in vitro Antitumor Effects of Interleukin 1 (IL 1)
  Immunobiology, 1986
• Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1
  Nature, 1986
• Demonstration of membrane receptors for human natural and recombinant ¹²⁵I‐labeled tumor necrosis factor on HeLa cell clones and their role in tumor cell sensitivity
  European Journal of Biochemistry, 1986
• Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
  The Journal of Experimental Medicine, 1986